*Department of Medicine, Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC;
†Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC;
‡Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, NC; and
§Blood Research Center, University of North Carolina School of Medicine, Chapel Hill, NC.
Reprints: Harish Eswaran, MD, Division of Hematology, Department of Medicine, University of North Carolina School of Medicine, 170 Manning Drive CB#7305, Chapel Hill, NC 27599-7305 (e-mail: [email protected]).
Dr. Traub has received research funding from Alnylam Pharmaceuticals, Ionis pharmaceuticals, Argenx, and Pharnext. The remaining authors report no conflicts of interest.
